Skip to content
1st Counsel – Lifestyle
Author:
Regenerative Medical Technology Group
RMTG Expands Peptide Education Platform With ISSCA Peptide Certification 2.0 and New Physician Reference Guides
October 1, 2026
RMTG’s ISSCA Division to Host ISSCA 125 Global Summit in Cancún, Mexico
September 21, 2026
RMTG’s ISSCA Division Launches Integrative Fellowship in Point-of-Care Regenerative Medicine through ISSCA AI(TM) Strategy
September 17, 2026
Regenerative Medical Technology Group, Inc. Details Expanded ISSCA AI(TM) Clinical Intelligence Platform, Including Protocol-Native Engine, Structured Data Assets, and Multi-Line Commercial Model
September 14, 2026
RMTG Cellgenic Begins Commercial Activity in Colombia
September 8, 2026
Cellgenic Establishes Local Commercial Presence in Brazil
September 3, 2026
RMTG’s Cellgenic Commences Commercial Activity in Peru, Extending Its Latin American Footprint
September 1, 2026
RMTG’s Cellgenic Division Introduces MUSE Cell Product Line Across Four International Regions
August 27, 2026
RMTG Acquires RMTG.com Domain and Launches New Investor-Focused Website, Advancing Shareholder Engagement
August 26, 2026
RMTG’s Cellgenic Division Launches Natural Killer (NK) Cell Product Line for International Markets
August 24, 2026
1
2
Next Page
→